Proto-oncogenes and cancer development
Pro Research Analysisby 
Searched over 200M research papers
Proto-Oncogenes: Definition and Role in Normal Cell Function
Proto-oncogenes are normal genes found in all cells that play a key role in regulating cell growth, division, and differentiation. They are essential for healthy development and tissue maintenance, as they help control when and how cells multiply and mature 247.
Activation of Proto-Oncogenes and Cancer Development
When proto-oncogenes are altered by genetic changes, they can become oncogenes—genes that drive uncontrolled cell growth and cancer. This transformation, known as proto-oncogene activation, can occur through several mechanisms, including point mutations, gene amplification, chromosomal translocations, and gene rearrangements 1234. These changes remove the normal regulatory controls, giving cells a growth advantage and promoting tumor formation 2347.
Key Mechanisms of Proto-Oncogene Activation in Cancer
- Point Mutations: Small changes in the DNA sequence can activate proto-oncogenes, as seen with the ras gene in many human and rodent tumors 13.
- Gene Amplification: An increase in the number of copies of a proto-oncogene can lead to overexpression, which is often observed in late-stage tumors but can also occur early, such as with HER2/neu in breast cancer 13.
- Chromosomal Translocations and Rearrangements: These events can fuse proto-oncogenes with other genes, leading to abnormal activation. For example, the ERG and TMPRSS2 gene fusion is common in prostate cancer, and RET rearrangements are seen in thyroid and other cancers 16910.
- Insertional Mutagenesis and Transduction: These less common mechanisms can also activate proto-oncogenes, especially in the context of viral infections .
Examples of Proto-Oncogenes in Human Cancers
- RAS Family: The ras proto-oncogenes are among the most frequently activated in human cancers, often serving as an early event in tumor development 13.
- MYC: MYC proto-oncogenes are master regulators of cell growth and are commonly upregulated in many cancers, driving both tumor growth and immune evasion .
- RET: RET proto-oncogene activation, through mutations or rearrangements, is linked to several cancers, including thyroid, lung, and inherited cancer syndromes like multiple endocrine neoplasia type 2 (MEN 2) 910.
- ERG: Overexpression of the ERG proto-oncogene, often due to gene fusion, is central to prostate cancer progression and metastasis .
Proto-Oncogenes, Tumor Suppressors, and Cancer Progression
Cancer development is not only driven by proto-oncogene activation but also by the inactivation of tumor-suppressor genes, such as p53. The combination of these genetic changes leads to uncontrolled cell proliferation, resistance to cell death (apoptosis), and other cancer hallmarks like angiogenesis and metastasis 137.
Clinical Implications: Diagnosis and Treatment
Understanding proto-oncogene activation has led to new diagnostic and therapeutic strategies. Genetic testing for specific proto-oncogene mutations, such as RET in MEN 2, allows for early diagnosis and targeted surveillance . Targeted therapies, including kinase inhibitors for RET and agents under development for MYC-driven cancers, are being explored to block the effects of activated oncogenes 89.
Conclusion
Proto-oncogenes are crucial for normal cell function but can drive cancer when activated by genetic changes. Multiple mechanisms—including mutations, amplification, and gene fusions—can convert proto-oncogenes into oncogenes, leading to uncontrolled cell growth and tumor development. Advances in understanding these processes are improving cancer diagnosis, prognosis, and the development of targeted therapies 1234+5 MORE.
Sources and full results
Most relevant research papers on this topic